Cannabis pilot study: THCV blocks some of the negative effects its chemical cousin THC

Scientists have begun examining tetrahydrocannabivarin, a little-known components of cannabis. Their preliminary findings suggest the chemical can inhibit some of the negative effects of cannabis’s main component.

Cannabis sativa produces more than 100 chemical compounds that act on cannabinoid receptors in the brain. Of these chemicals, which are known simply as cannabinoids, the most common are tetrahydrocannabinol (THC) and cannabidiol (CBD). Tetrahydrocannabivarin (THCV) also naturally occurs in cannabis, but typically in very low quantities.

The drug was “well tolerated among the participants,” many of whom could not distinguish the THCV capsules from the placebo capsules, the researchers reported. Four out of the ten volunteers incorrectly guessed which week they had been given the THCV capsules.In a double-blind study, researchers from King’s College London administered 10mg of THCV or placebo capsules to ten healthy male volunteers for four days before injecting them with 1mg of THC on the fifth day. After...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.